Of note, several HDACi or HDAC6i are currently in clinical trials for cancer treatment, clearly indicating HDAC inhibition to induce DNA damage as an efficient genotoxic treatment for cancer therapy [33,34,35,36]. This evidence concerns the gene HDAC9 and cancer.